The 2 UK shares I would buy before the year ends

As 2020 draws to a close, here are the top two UK shares I would buy before the New Year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As 2020 draws to a close, it is natural for investors to look back over the year. It has been a tough one for most, and Covid-19 has dominated markets and news headlines alike. Looking forward to 2021 however, I think there are opportunities to be had. This is why I am looking at my choice of two UK shares to pick up this side of the New Year.

My criteria for considering these my top UK shares

Here I am considering stronger, well branded firms in the FTSE 100, which in the current climate gives me the risk/reward profile I am looking for. With this in mind, here are my top two UK shares to buy today.

AstraZeneca

To a certain extent, AstraZeneca (SLE: AZN) has moved into my number one choice of UK shares to buy right now. Naturally, it is seeing a lot of interest as a result of its Covid-19 vaccine. For me, though, this only adds to the appeal of the share as an investment.

It seems unlikely the vaccine will really help boost the company’s profits in the short term. In the long run, however, an increased interest in pandemics and vaccines should see Astra get significant government support.

I also think now may be the perfect time to get the company at a bargain price. The stock is seeing pressure following the announcement of AstraZeneca’s $39bn acquisition of US biotech firm Alexion. Alexion will be adding significantly to Astra’s portfolio, and also brings in a nice positive cash flow. I think the acquisition will be positive long term.

BP

I have long been a fan of BP (LSE: BP). In the past, its appeal was mainly as a strong income share, but at the moment it also offers potential growth. As with the other oil majors, Covid-19 and travel bans have been weighing on the shares price this year.

This is the classic relationship between oil producers and the price of crude. However as oil prices start to recover, so too will related stocks. I think BP could be the perfect pick of UK shares right now.

I am of the opinion that Covid-19 acted more as a catalyst for the oil price slump. The straw that broke the camel’s back, so to speak, in a market that was already worried. The crude market does have some fundamental weaknesses regardless of Covid-19 – chiefly a large amount of spare capacity. However Russia and OPEC, both of whom dominate oil production, are likely to keep output low to artificially bolster prices.

I doubt 2021 will see oil prices sky rocket, but BP doesn’t need them to. Combined with the potential increase in its dividend if and when that comes forward, for me this makes BP look like a decent UK share to pick up right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Karl has shares in AstraZeneca and BP. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »